ACSS3 and Hepatic steatosis: Pharmacologically inhibition of autophagy by HCQ/wortmannin inhibits propionate‐induced autophagy in vitro, and HCQ treatment ameliorates obesity, hepatic steatosis and insulin resistance of the Acss3–/– mice in vivo.